Look At Analyst Expectations For A Better Read On Relay Therapeutics Inc (NASDAQ: RLAY)
Currently, there are 170.48M common shares owned by the public and among those 128.57M shares have been available to trade. The company’s stock has a 5-day price change of 1.61% and -31.97% over the past three months. RLAY shares are trading -23.54% year to date (YTD), with the 12-month market performance down to -55.51% lower. […]
Assessing Whether Relay Therapeutics Inc (NASDAQ: RLAY) Is Over- Or Undervalued
Relay Therapeutics Inc (RLAY) concluded trading on Wednesday at a closing price of $3.33, with 4.07 million shares of worth about $13.56 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -44.68% during that period and on April 30, 2025 the price saw a […]